Organon & Co.
OGN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821825
In the last 90 days, Organon & Co. insiders filed 0 open-market purchases and 1 sale; 636 institutions reported holding it in 13F filings for Q2 2026, worth $2.92B in total; no superinvestor holds it.
Superinvestors holding OGN, Q2 2026
No superinvestor reported holding OGN in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of OGN each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2021
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q3 2021
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+528.8%)
- Sold out
- Berkshire Hathaway, Fairfax Financial
Q2 2021
3 superinvestors holding at quarter end